Ruth Berry
Director, Analytical Development Strategy @ GentiBio
About Ruth Berry
Ruth Berry is the Director of Analytical Development Strategy and holds a PhD.
Known information
Ruth Berry serves as the Director of Analytical Development Strategy, a role that involves overseeing and guiding the strategic direction of analytical development within her organization. She holds a PhD, indicating a high level of expertise and specialization in her field. Her position likely requires a deep understanding of analytical methodologies and the ability to integrate these strategies effectively to support the organization’s goals.
About GentiBio
GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.